Researchers at the MTN include international investigators and community and industry partners who work together to evaluate promising microbicide products.
More than 25 clinical research sites on four continents have partnered with the Microbicide Trials Network in the conduct of its clinical trials.
Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The Microbicide Trials Network brings together international investigators and community and industry partners whose work is focused on the rigorous evaluation of promising microbicides.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
MTN is excited to announce that MTN-033 has completed enrollment.
Microbicide Trials Network Research Prominent at 2018 HIV R4P.
MTN is excited to announce the launch of MTN-037.
Save the date for the upcoming MTN 2019 Annual Meeting.
Presentations from the MTN 2018 Regional Meeting have been posted.
The stakeholders consultation meeting report for MTN-042 has been posted to our website.
First clinical trial of new dapivirine ring with both anti-HIV drug and contraceptive finds ring is well-tolerated with no safety concerns
Sensitive ARV resistance tests detect no dapivirine-associated resistance among women using dapivirine vaginal ring in ASPIRE
Researchers present additional evidence on the safety of the dapivirine vaginal ring
Microbicide Trials Network